clinical trial · NCT06932757
Adjuvant Quisinostat in High-Risk Uveal Melanoma
University of Miami·phase2·recruiting·n = 63
Uveal MelanomaQuisinostat
brief summary
The purpose of this study is to see if giving participants quisinostat will prevent participants' uveal melanoma tumor from spreading. The researchers want to find out the effects that quisinostat has on participants' condition.
started
May 27, 2025
primary completion
May 27, 2030
completion
May 27, 2030
last updated
Jun 18, 2026
official title
Phase 2 Trial of Adjuvant Quisinostat in High-Risk Uveal Melanoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol